The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak-STAT Signaling Pathway: A Case-control Study.

Aysan Jafari Harandi Alireza Mirzaee Sedigh Mitra Ataei Sepideh Bayrami Emran Esmaeilzadeh Mohammad Hossein Sanati

Published in: Iranian journal of immunology : IJI (2024)

Our findings suggest that the positive effects of IFN-β and NTZ in the RRMS patients could be potentially mediated by returning miR-20b expression to baseline.

Keyphrases

multiple sclerosis
poor prognosis
signaling pathway
end stage renal disease
white matter
ejection fraction
newly diagnosed
dendritic cells
chronic kidney disease
immune response
peritoneal dialysis
prognostic factors
binding protein
cell proliferation
systemic lupus erythematosus
patient reported